CHICAGO (WLS) -- A woman who was set on fire on a CTA Blue Line train back in November is now out of the hospital. She thanked hospital staff for their care as she celebrates this milestone in her ...

Elon Musk’s SpaceX said Monday it is acquiring artificial-intelligence startup xAI, a move that significantly expands the rocket and satellite company’s ambitions in data centers and advanced ...

The first big video game release of 2026 is only a few weeks away, and when it arrives, Xbox Series X users won’t be able to play, at least not on an Xbox Series X. If they want to play the first big ...

BOSTON (WHDH) - Getting around the city was made easier Tuesday after the Green Line reopened after a two-week shutdown affecting all branches. The MBTA needed the closure to replace underground beams ...

Bourbon maker Jim Beam plans to pause production at its main US distillery for all of 2026 after slumping demand caused an oversupply of whiskey. The brand, owned by Japanese alcohol giant Suntory ...

CLERMONT, Ky. (AP) — Bourbon maker Jim Beam is halting production at one of its distilleries in Kentucky for at least a year as the whiskey industry navigates tariffs from the Trump administration and ...

Add Yahoo as a preferred source to see more of our stories on Google. The wooden beams that ran along the ceilings of the MBTA’s Green Line tunnels were installed when the line was built in the late ...

CHICAGO (WGN) – A grand jury has indicted a man on charges related to an incident where he allegedly set a young woman on fire while aboard a CTA Blue Line train, and another incident where he ...

KITCHENER, Ontario --Gavin McKenna and Brady Martin grew up worlds apart from each other. Three time zones and about 3,300 miles apart. That’s the distance between Whitehorse, Yukon, McKenna’s ...

Tony Vitello was a fish out of water at his first ever Winter Meetings. "I don't know what I'm doing at this thing, to be honest with you," the new San Francisco Giants manager admitted last Tuesday ...

Enhertu, a targeted cancer therapy from partners AstraZeneca and Daiichi Sankyo, may now be used as a first-line treatment for advanced cases of breast cancer, making it the first new approved ...